Institutional shares held 30.3 Million
30.8K calls
152K puts
Total value of holdings $376M
$381K calls
$1.88M puts
Market Cap $185M
14,941,300 Shares Out.
Institutional ownership 202.83%
# of Institutions 107


Latest Institutional Activity in CELC

Top Purchases

Q3 2024
Citadel Advisors LLC Shares Held: 775K ($9.61M)
Q3 2024
State Street Corp Shares Held: 1.11M ($13.7M)
Q3 2024
Braidwell LP Shares Held: 884K ($11M)
Q3 2024
Exodus Point Capital Management, LP Shares Held: 691K ($8.57M)
Q3 2024
Saturn V Capital Management LLC Shares Held: 946K ($11.7M)

Top Sells

Q3 2024
Morgan Stanley Shares Held: 1.39M ($17.3M)
Q3 2024
Balyasny Asset Management LLC Shares Held: 328K ($4.07M)
Q3 2024
Marshall Wace, LLP Shares Held: 11.9K ($147K)
Q3 2024
Pfm Health Sciences, LP Shares Held: 710K ($8.81M)
Q3 2024
Verition Fund Management LLC Shares Held: 39.9K ($495K)

About CELC

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.


Insider Transactions at CELC

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
2.83M Shares
From 5 Insiders
Grant, award, or other acquisition 1.08K shares
Bona fide gift 2.82M shares
Exercise of in-the-money or at-the-money derivatives securities 5.06K shares
Exercise of conversion of derivative security 250 shares
Sell / Disposition
2.82M Shares
From 3 Insiders
Bona fide gift 2.82M shares
Open market or private sale 1.75K shares

Track Institutional and Insider Activities on CELC

Follow Celcuity Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CELC shares.

Notify only if

Insider Trading

Get notified when an Celcuity Inc. insider buys or sells CELC shares.

Notify only if

News

Receive news related to Celcuity Inc.

Track Activities on CELC